matching in this field. Differences in outcomes after kidney transplantation related to donor-recipient sex concordance have been attributed to mismatches in graft size, nephron mass or vessel diameter, or small-for-size in liver transplantation. 6, 20, 21 It has also been postulated that estrogen and testosterone levels and their impact on ischemia/reperfusion injury 22 as well as immunologic factors such as the H-Y antigen may play a role in this context. 6, 23, 24 The importance of sex matching has been investigated in the setting of pancreas transplantation; however, only few reports address the impact of recipient and donor sex as well as sex matching on the outcome after pancreas transplantation. [25] [26] [27] [28] A large US registry study recently reported that sex matching significantly decreased the risk for pancreas graft failure. 25 As a substantial impact of sex matching on postoperative outcome could potentially impact organ allocation and postoperative monitoring, we herein investigate the effect of donor-recipient sex concordance on short-and long-term outcomes after pancreas transplantation in a single-center cohort of one of the highest-volume pancreatic transplant centers in the Eurotransplant region. 
| MATERIAL S AND ME THODS

| Study population
| Surgical procedure
| Immunosuppressive regimens
In transplants performed before 1997, only two patients ( 
| Definitions
| Outcome parameters
Primary outcome parameters were patient survival and death-censored pancreas graft survival (dcPGS). Secondary outcome parameters were odds of PDGF, independence of insulin upon hospital discharge, severe postoperative complications (Clavien-Dindo Grade ≥ 3b), immunologic complications, and a length of hospital stay >25 days, as this represents the median length of hospital stay in our cohort.
| Statistical analysis
Results are expressed as mean ± standard deviation (SD) for continu- 
| Impact of donor and recipient sex on patient survival and pancreas graft survival
Patient survival was similar between recipients of female and male donor organs (log-rank P = .44; Figure 1A ) and between female and male recipient sex (log-rank P = .54; Figure 1B ). As well, dcPGS showed no statistically significant difference regarding donor (log-rank P = .11; Figure 1C ) or recipient (log-rank P = .17; Figure 1D ) sex. Though not statistically significant, recipients of male donor organs and male recipients receiving organs from either sex had a trend toward superior dcPGS.
| Impact of donor and recipient sex match on patient survival and pancreas graft survival
Patient survival, dcPGS, and dcKGS were similar between sexmatched and sex-mismatched transplants (Figure 2A , log-rank P = .86; Figure 2B , log-rank P = .26, Figure 3A , log-rank P = .24 Table 5 ). 
| Impact of donor and recipient sex match on secondary outcome parameters
| Impact of donor and recipient sex match on patient survival and pancreas graft survival by era of transplantation
Of the entire cohort, 104 (23.0%) SPK transplants were performed before and 348 (77%) after 1997. In the earlier era, sex-matched pancreas transplants were associated with a trend toward better patient survival ( Figure 3A , log-rank P = .07) as well as dcPGS ( Figure 3C , log-rank P = .053) without reaching statistical significance; dcKGS was similar in both groups ( Figure 3E , log-rank P = .2). One-, 5-, 10-, 13; E, log-rank P = .37) and after 1997 (G, log-rank P = .51; H, log-rank P = .37). From 1979-2017, significant differences were found in dcKGS (C, log-rank P = .015). However, after splitting the cohort in an era before (F, log-rank P = .1) and after 1997 (I, log-rank P = .58), dcKGS was similar between the four possible sex combinations 
| Impact of donor-recipient sex constellations on patient survival and graft survival and secondary outcome parameters
(D) p=0.51 (G)
| D ISCUSS I ON
The present study investigates the impact of donor-recipient sex matching on short-and long-term outcomes after pancreas trans- and dcKGS more in transplants performed before 1997.
As described previously by our center 29 29, 32 Also, in sex-mismatched transplants, inferior outcomes and increased rates of graft rejection have been reported. 6, 7, 19, 23, 33, 34 Along with hormonal and size-related factors, the H-Y antigens have been hypothesized to account for this observation. These are minor histocompatibility antigens encoded on the Y chromosome containing regions of high immunogenicity. 24, 35 Their role has been highlighted in hematopoietic cell transplantation, where grafts from female donors to male recipients lead to an increased risk of graftversus-host disease but a decrease in non-relapse mortality and, in some studies, a lower relapse rate. 23, 36, 37 Unfortunately, the importance of sex mismatch in solid organ To date, few studies exist focusing on the impact of sex on the outcome after pancreas transplantation. Li et al examined the influence of donor-recipient sex mismatch on the long-term survival of pancreatic grafts in a large registry study (n = 24,195) using the Scientific Registry of Transplant Recipients (SRTR). 25 As described in our population, they found that recipient and donor sex individually had no impact on PGS. In contrast to our findings, however, they reported that sex-matched donor-recipient pancreas transplant pairings resulted in a significant reduction in PGF. In a single-center study (n = 163), Colling et al 26 missing for recipients prior to 1997. Therefore, these patients were not included in the multivariable models. Based on the split demographics, several confounding variables including donor age, donor height, donor cause of death, creatinine levels at discharge, and PDRI were identified which may have disadvantaged mismatched groups and potentially bias reported long-term outcomes. As well, though this study, to our knowledge, represents one of the largest single-center studies on this topic with the longest follow-up thus far, it might be underpowered to detect differences in outcomes between the two groups and especially in the stratified donor-recipient sex combinations.
In summary, our data show no influence of sex matching on early postoperative outcome, patient survival, dcPGS, or dcKGS in transplants performed either before or after 1997. Factors associated with PGF were a high PDRI, donor age and BMI, postoperative complications, year of transplantation, and transplants performed before 1997. Thus, it can be concluded that in the modern era with current techniques and immunosuppression, transplanting sex-mismatched organs is a safe practice that we should continue to perform to offset organ shortage.
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